IMS MAXIMS Celebrates Major New Investment

IMS MAXIMSLeading healthcare IT supplier IMS MAXIMS has announced a major new investor, laying the foundations for future growth. Thomas Anderson, who has taken full ownership of the company, and CEO Shane Tickell, have now outlined their ambitions to build IMS MAXIMS into a substantial force in international healthcare IT.

Mr Anderson is best known for being the principal of the Empire Cinema Group. He also has a keen interest in both the IT and healthcare industries and this acquisition allows him to combine these.

Mr Anderson said: "IMS MAXIMS has proven software which enables clinicians in the UK and Ireland to deliver the best possible healthcare services to millions of patients.

"I have a passionate belief in Irish business and am convinced that IMS MAXIMS has the products, the vision, and the leadership to make a truly significant contribution to improving healthcare in Ireland, the UK, Europe and beyond. I look forward to working with Shane and his team in the years ahead and to IMS MAXIMS going from strength to strength."

The news was announced at a hearing of the High Court in Dublin during which the company was declared to be financially sound and was released from a form of temporary protection, known as Examinership. IMS MAXIMS, which is headquartered in Dublin, was accepted into Examinership in August after its former parent company ran into difficulties. This provided the opportunity to find an investor to recapitalise and ensure the growth of the business.

Shane Tickell said: "Thanks to this new investment we are better placed than ever for growth and success. It's excellent news for IMS MAXIMS and its customers that we have secured the backing of someone with Thomas Anderson's business skills and commitment to Irish enterprise. He has a clear appreciation of the quality of our existing products and of the excellence of our R&D, which will allow us to expand by offering new advanced software solutions to clients in the public and independent sectors, at home and overseas.

"We conducted business as usual throughout the Examinership, which demonstrates the high levels of confidence our customers have in IMS MAXIMS and its products. In the last few weeks we have even announced a new series of options which give customers even more choice over how they access our clinical and administrative software. In the coming months we will make further announcements, underlining that this is a vibrant and energetic business with a huge amount to offer the world of healthcare."

Mr Anderson's investment will provide IMS MAXIMS with the necessary resources for further product improvements and reduced delivery times. The company will now be able to develop its medium and long-term strategy to expand its portfolio of products and services and establish a global presence.

About IMS MAXIMS
IMS MAXIMS is the company behind the widely-used MAXIMS clinical PAS. It is a specialist in developing clinical and administrative software solutions and currently supports more than 150 organisations, 1.9 million patient records in Ireland and 8 million patient records in the UK, as well as 10,000 users of IMS MAXIMS products.

About the MAXIMS clinical PAS
MAXIMS gives clinicians the applications they need to provide the best possible patient care, and allows provider organisations to manage their patient administration with ease and efficiency. Rival products often tend to be administrative systems with clinical software added on. MAXIMS is equally focused on the needs of clinicians and provider organisations - which we believe is the way to guarantee the best patient outcomes with optimum efficiency.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...